New data from Statistics Denmark reveals that ADHD medication use has more than doubled since 2020, with a marked increase among girls and women. Experts point to shifting diagnosis patterns and geographic differences across the country.
ADHD Medication Use Doubles in Four Years
The number of Danes using prescription ADHD medication has soared. According to new figures from Statistics Denmark, 133,000 people filled a prescription for these drugs in 2024 compared to about 61,000 in 2020. That means the number of users has more than doubled in just four years. Looking back to 2010, the figure has quadrupled.
Psychostimulant medications, often called psychoanaleptics, are used to treat ADHD and other conditions affecting the brain and nervous system. The sharp rise in prescriptions, experts say, reflects both more diagnoses and growing awareness of the disorder across different groups in society.
More Women and Girls Are Now Diagnosed
For many years, ADHD was seen as a boys’ condition, associated with hyperactivity and disruptive behavior. That stereotype is changing quickly. New statistics show that for the first time, more women and girls received treatment than men and boys in 2024. This marks a major shift in how ADHD is identified and managed.
Interestingly, girls tend to receive their diagnosis much later than boys. While symptoms in boys are often noticed around age eight, girls typically receive their diagnosis around age seventeen. Because girls often present with inattentive rather than hyperactive behavior, their symptoms can stay unnoticed for years. As a result, some may miss out on timely treatment and support, leading to additional difficulties later in life.
Unequal Distribution Across Denmark
The data also highlights significant geographic differences in ADHD medication use. On the island of Bornholm, 3.5 percent of residents were prescribed ADHD medication in 2024, the highest rate in the country. Norddjurs and Struer municipalities followed closely with 3.2 and 3.1 percent.
At the other end of the scale, Fanø and Læsø municipalities reported the lowest shares of residents receiving prescriptions. Similar disparities appear among children: in some areas, only one percent receive medication, while in others up to six percent do.
These differences cannot be explained by population health alone. Experts suggest that local medical practices and varying interpretations of national guidelines play a major role. The inconsistencies highlight challenges within the Danish healthcare system and point to the need for more standardized diagnostic and treatment approaches.
Changing Awareness and Social Implications
The increase in diagnoses and medication use likely reflects improved public understanding of ADHD. Growing awareness through social media, broader access to mental health services, and conversations about neurodiversity have encouraged more people to seek evaluation.
At the same time, the healthcare system faces pressure to provide equitable support nationwide. Long wait times for evaluations remain a concern, particularly for young people. Access to prescription treatment depends not only on clinical need but also on whether individuals can navigate the system effectively.
Denmark’s evolving approach to ADHD shows that mental health awareness continues to expand across age and gender lines. While this development has helped many who were previously overlooked, it also calls for more coordination between doctors, schools, and mental health professionals to ensure consistent care across the country.
Sources and References
The Danish Dream: Danish Healthcare Explained for Tourists & Expats
The Danish Dream: Mental Health in Denmark for Foreigners
TV2: Forbruget af ADHD-medicin er fordoblet
